The most important part of this video at 13:13 My take is #1 Paxlovid, #2 VV116 (民得维). if neither is availale, I would consider molnupiravir or China's own 3CLpro inhibitor. More importantly, treatment is usually indicated for high risk groups (eg: elderly, immunocompromised). Young, healthly people with 3 or more doses of vaccines don't really need these drugs but Pax is approved for adult. VV116 has less drug drug interaction makes it a very attractive alternative, but more studies are needed to recommend it over Paxlovid.
